<Disease><Name>CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (CMH6)</Name><Synonym>PRKAG2</Synonym><OMIM><Number>600858</Number><URL>http://omim.org/entry/600858</URL></OMIM><Orphanet><Number>439854</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=439854</URL></Orphanet><Protein><Number>5'-AMP-activated protein kinase subunit gamma-2</Number><URL>https://www.uniprot.org/uniprot/Q9UGJ0</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>7q36.1</Gene><ICD /><Summary>very rare;autosomal dominant;mutation in the PRKAG2 gene;glycogen accumulation in the cardiac tissue;We highlight the potential for patients with ;PRKAG2; mutations to mimic Pompe disease in infancy and the need for confirmatory testing when diagnosing Pompe disease [Torok RD 2017]</Summary><Symptoms><symtomp><id>1875</id><symptom>bradycardia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2459</id><symptom>cardiac arrhythmia, dysrhythmia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3677</id><symptom>cardiomyopathy, hypertrophic</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1883</id><symptom>ECG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3985</id><symptom>nephropathy</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3986</id><symptom>Wolf-Parkinson-White syndrome</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>7889</id><title>Novel PRKAG2 Variant Manifesting with a Cardiac Arrest in a Child.</title><author>Spentzou G,</author><journal>Pediatr Cardiol</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7890</id><title>Patient with a PRKAG2 mutation who developed Immunoglobulin A nephropathy: a case report</title><author>Giudici MC,</author><journal>Eur Heart J Case Rep</journal><year>2019</year><book /><volume>3</volume><number>2</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7891</id><title>A Case Series on Cardiac and Skeletal Involvement in Two Families with PRKAG2 Mutations</title><author>Sri A,</author><journal>Case Rep Pediatr</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al,.</co_aut></literature><literature><id>7892</id><title>Infantile Onset Hypertrophic Cardiomyopathy Secondary to PRKAG2 Gene Mutation is Associated with Poor Prognosis</title><author>Gorla SR,</author><journal>J Pediatr Genet</journal><year>2018</year><book /><volume>7</volume><number>4</number><pages>180-184</pages><co_aut>et al.</co_aut></literature><literature><id>7893</id><title>High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations: comme</title><author>Qiu J,</author><journal>Europace</journal><year>2018</year><book /><volume>20</volume><number>8</number><pages>1389</pages><co_aut>et al.</co_aut></literature><literature><id>7894</id><title>Cardiac manifestations of PRKAG2 mutation</title><author>Banankhah P,</author><journal>BMC Med Genet</journal><year>2018</year><book /><volume>19</volume><number>1</number><pages>1</pages><co_aut>et al.</co_aut></literature><literature><id>7895</id><title>PRKAG2 mutations presenting in infancy</title><author>Torok RD,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>40</volume><number>6</number><pages>823-830</pages><co_aut>et al.</co_aut></literature><literature><id>7896</id><title>A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation</title><author>Yang KQ,</author><journal>Sci Rep</journal><year>2017</year><book /><volume>7</volume><number>1</number><pages>2407</pages><co_aut>et al.</co_aut></literature><literature><id>7897</id><title>High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations</title><author>Thevenon J,</author><journal>Europace</journal><year>2017</year><book /><volume>19</volume><number>4</number><pages>651-659</pages><co_aut>et al.</co_aut></literature><literature><id>7898</id><title>Clinical Spectrum of PRKAG2 Syndrome</title><author>Porto AG,</author><journal>Circ Arrhythm Electrophysiol</journal><year>2016</year><book /><volume>9</volume><number>1</number><pages>e003121</pages><co_aut>et al.</co_aut></literature><literature><id>7899</id><title>Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations</title><author>P&#246;yh&#246;nen P,</author><journal>J Cardiovasc Magn Reson</journal><year>2015</year><book /><volume>17</volume><number>0</number><pages>89</pages><co_aut>et al.</co_aut></literature><literature><id>7900</id><title>PRKAG2 mutation: An easily missed cardiac specific non-lysosomal glycogenosis</title><author>Aggarwal V,</author><journal>Ann Pediatr Cardiol</journal><year>2015</year><book /><volume>8</volume><number>2</number><pages>153-156</pages><co_aut>et al.</co_aut></literature><literature><id>7901</id><title>Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure</title><author>Liu Y,</author><journal>PLoS One</journal><year>2013</year><book /><volume>8</volume><number>5</number><pages>e64603</pages><co_aut>et al.</co_aut></literature><literature><id>7903</id><title>A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis</title><author>Laforet P,</author><journal>Neuromuscul Disord</journal><year>2006</year><book /><volume>16</volume><number>3</number><pages>178-182</pages><co_aut>et al.</co_aut></literature><literature><id>7902</id><title>Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinas</title><author>Burwinkel B,</author><journal>Am J Hum Genet</journal><year>2005</year><book /><volume>76</volume><number>6</number><pages>1034-1049</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>